These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35166787)

  • 1. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic.
    Zhou JZ; Kane S; Ramsey C; Akhondzadeh M; Banerjee A; Shatsky R; Gold KA
    JAMA Netw Open; 2022 Feb; 5(2):e2148581. PubMed ID: 35166787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
    Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
    Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.
    Halloran SP
    Prev Med; 2021 Oct; 151():106539. PubMed ID: 34217407
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 impact on incidence and stage at diagnosis of five prominent cancers: A French cancer registry-based study.
    Demoustier B; Seigneurin A; Jacquet E; Delafosse P; Riedel C; Epaulard O; Laramas M
    J Epidemiol Popul Health; 2024 Oct; 72(5):202555. PubMed ID: 38968693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic.
    Khan MMM; Munir MM; Khalil M; Pawlik TM
    Ann Surg Oncol; 2024 Jul; 31(7):4563-4564. PubMed ID: 38653940
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast and Colorectal Cancer Screening Utilization after Hurricane María and the COVID-19 Pandemic in Puerto Rico.
    Colón-López V; Contreras-Mora HM; Pérez CM; Berríos-Ortiz H; Sánchez-Díaz CT; Disdier OM; Ríos-Morales N; Suárez-Pérez EL
    Int J Environ Res Public Health; 2023 Oct; 20(19):. PubMed ID: 37835140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Semenov S; Ismail MS; McNamara D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):426. PubMed ID: 34015353
    [No Abstract]   [Full Text] [Related]  

  • 16. Impairment of colorectal cancer screening during the COVID-19 pandemic.
    Laghi L; Cameletti M; Ferrari C; Ricciardiello L
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):425-426. PubMed ID: 34015352
    [No Abstract]   [Full Text] [Related]  

  • 17. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Lou J; Kooragayala K; Williams JP; Sandilos G; Butchy MV; Yoon-Flannery K; Kwiatt M; Hong YK; Shersher DD; Burg JM
    Am J Clin Oncol; 2022 Sep; 45(9):381-390. PubMed ID: 35983965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan.
    Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T
    JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK.
    Borsky K; Shah K; Cunnick G; Tsang-Wright F
    Future Oncol; 2022 Feb; 18(4):437-443. PubMed ID: 35018787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Collateral damages of the Covid-19 pandemic in breast cancer screening].
    Villaseñor-Navarro Y; Sollozo-Dupont I
    Salud Publica Mex; 2021 Jun; 63(4):461. PubMed ID: 35077083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.